neoadjuvant cemiplimab in patients with stage ii-iv cutaneous squamous cell carcinoma
Published 1 year ago • 885 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:42
dr. gross on neoadjuvant cemiplimab in head and neck cutaneous squamous cell carcinoma
-
1:28
dr. rischin discusses cemiplimab in cutaneous squamous cell carcinoma
-
6:45
integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma
-
1:40
matisse: nivolumab in cutaneous squamous cell carcinoma
-
1:38
dr. pavlick on longer follow-up data with cemiplimab in cscc
-
6:31
fda d.i.s.c.o.: fda approval of cemiplimab-rwlc for cutaneous squamous cell carcinoma
-
1:28
frontline libtayo could help patients with advanced cutaneous squamous cell carcinoma avoid surgery
-
3:07
dr gross on the neoadjuvant utility of cemiplimab in cscc
-
2:36
cemiplimab in advanced bcc
-
0:52
benefit with cemiplimab in patients with mcscc
-
3:08
[skin] effects of cemiplimab used before skin cancer surgery
-
16:23
neoadjuvant therapy for nmsc
-
1:09
clinical implications of neoadjuvant immunotherapy in cscc
-
1:23
i-tackle: io followed by cetuximab in la/metastatic cutaneous squamous cell carcinomas
-
4:13
cemiplimab in managing advanced cscc
-
0:52
phase ii shows antitumor activity with cemiplimab in mcscc
-
1:59
role of neoadjuvant and precision therapeutics in advanced basal cell carcinoma
-
8:16
cutaneous squamous cell carcinoma: what is immunotherapy?
-
2:43
tumor characteristics of patients with recurrence after neoadjuvant ipi nivo in melanoma